PEP
33
4
EA
41
3
XOM
33
3
AON
25
4
HIG
48
5
CAH
44
7
AN
49
2
PSA
43
6
BAX
38
2
GM
55
6
UHS
50
4
ROK
46
3
IPG
43
3
NWL
48
4
MU
42
14
GRMN
53
3
CMCSA
49
3
KEY
24
2
MA
60
5
HPE
48
2
PEP
33
4
EA
41
3
XOM
33
3
AON
25
4
HIG
48
5
CAH
44
7
AN
49
2
PSA
43
6
BAX
38
2
GM
55
6
UHS
50
4
ROK
46
3
IPG
43
3
NWL
48
4
MU
42
14
GRMN
53
3
CMCSA
49
3
KEY
24
2
MA
60
5
HPE
48
2
Financhill
Back

Inovio Pharmaceuticals 10K Form

Sell
15

INO
Inovio Pharmaceuticals

Last Price:
$1.84
Seasonality Move:
21.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INO News And Ratings

See the #1 stock for the next 7 days that we like better than INO

INO Financial Statistics

Sales & Book Value

Annual Sales: $832K
Cash Flow: $-27.4M
Price / Cash Flow: 0
Annual Sales: $2.82
Price / Book: 0.65

Profitability

EPS (TTM): -4.47000
Net Income (TTM): $-112.9M
Gross Margin: $0
Return on Equity: -98.72%
Return on Assets: -70.72%

Inovio Pharmaceuticals Earnings Forecast

Key Inovio Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for INO is 0.00%.
  • The Selling, General & Administrative Expenses for INO have been equal to 5,718.93% of Gross Profit Margin.
  • The Research & Development expenses have been 10,417.73% of Revenue.
  • The Interest Expense is -0.90% of Operating Income.
  • The Net Earning history of INO is -16,239.87% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Inovio Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INO
CUSIP: 45773H
Website: inovio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.45
Quick Ratio: 4.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INO Technical Analysis vs Fundamental Analysis

Sell
15
Inovio Pharmaceuticals (INO) is a Sell

Is Inovio Pharmaceuticals a Buy or a Sell?